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The involvement of non-researcher contributors (eg, stakeholders, patients
and the public, decision and policy makers, experts, lay contributors) has taken
a variety of forms within evidence syntheses. Realist reviews are a form of evi-
dence synthesis that involves non-researcher contributors yet this practice has
received little attention. In particular, the role of patient and public involve-
ment (PPI) has not been clearly documented. This review of reviews describes
the ways in which contributor involvement, including PPI, is documented
within healthcare realist reviews published over the last five years. A total of
448 papers published between 2014 and 2019 were screened, yielding 71 full-
text papers included in this review. Statements about contributor involvement
were synthesized across each review using framework analysis. Three themes
are described in this article including nomenclature, nature of involvement,
and reporting impact.
Papers indicate that contributor involvement in realist reviews refers to
stakeholders, experts, or advisory groups (ie, professionals, clinicians, or aca-
demics). Patients and the public are occasionally subsumed into these
groups and in doing so, the nature and impact of their involvement become
challenging to identify and at times, is lost completely. Our review findings
indicate a need for the realist review community to develop guidance to sup-
port researchers in their future collaboration with contributors, including
patients and the public.
1 | INTRODUCTION
Researchers are increasingly being held to account to
involve non-researcher contributors in their research and
to provide accurate reporting of the nature of this
involvement.1,2 As a result, research teams increasingly
structure the research process into a variety of advisory,
expert or stakeholder meetings in order to account for
alternative perspectives within the design, production
and dissemination of research.
Evidence synthesis is one approach that has been
quick to involve contributors such as stakeholders (eg,
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content experts or clinicians). However, it has been
slower to navigate the more explicit involvement of
patients and public.3,4 Evidence synthesis is an umbrella
term for numerous ways of reviewing and synthesizing
secondary data. In addition to the mainstream Cochrane-
style systematic reviews and meta-analyses, this now
includes a range of alternative methods5 in which
researchers make interpretative and value-laden judg-
ments throughout the research process. There are a num-
ber of opportunities throughout the process therefore, for
individuals other than the immediate research team to
contribute.
One theory-driven approach to evidence synthesis is
realist reviewing. Realist reviews are a form of evidence
synthesis that take into account the complexities of an
intervention or innovation, producing causal explanations
about what works, for whom and in what contexts.6 We
have recently conducted several realist reviews about
healthcare organization and design7-11 that have involved a
range of contributors. We became aware that in our
reviews we approached this differently—both in terms of
who was involved and how. This observation made us curi-
ous as to whether this was the norm. Hence, we decided to
more systematically identify the ways in which non-
researcher contributor involvement has been used within
existing healthcare realist reviews. For the remainder of
this article, we use the term “contributor involvement” to
capture non-researcher involvement including (but not
limited to) stakeholders, patients and the public, decision
and policy makers, experts and lay contributors. Of partic-
ular interest for this review was the way in which patient
and public involvement (PPI) was reported (or not).
PPI refers to research carried out with and by mem-
bers of the public.12 Originating in the 1990s, PPI policies
aimed to democratize medicine and challenge the domi-
nant authority of and disillusion with healthcare decision-
making.13 PPI is often described as transforming the way
in which healthcare research is undertaken. It is hailed as
a means to improve efficiency and social accountability
and to balance power dynamics through a democratic dia-
logue.13 However, a long-standing issue with PPI is the
limited evidence available about both reporting the
involvement of patients and the public (ie, how and why)
and reporting the impact of PPI on research.14,15 Guidance
on involving patients and the public within realist reviews
has received much less attention than that in other forms
of evidence synthesis.16,17
2 | METHODS
This review examines the ways in which contributor
involvement is described within healthcare realist
reviews published since 2014. We chose to select articles
published from 2014 onwards because prior to this date
there were no expected standards to which realist reviews
could be held up to. The Realist And MEta-narrative Evi-
dence Syntheses: Evolving Standards (RAMESES) were
published in 2014; despite not setting any standards for
involving contributors, they acted as an international
standard for undertaking realist reviews more broadly.18
The purpose of this review was to (1) describe the
ways in which contributors have been involved in realist
reviews, with a particular focus on PPI and (2) document
how involvement has been reported. This review
responds to the research question, “in what ways have
contributors been involved in healthcare realist reviews
and how has this been reported?” and relatedly, “in what
ways are patients and the public involved (or not) in
healthcare realist reviews?”
2.1 | Search strategy
A search of four electronic databases, CINAHL
[EBSCOHost: 1982-15/3/2019], Embase [OvidSP: 1974-
15/3/2019], Medline [OvidSP: 1946-14/03/2019] and Psy-
cINFO [1806-March 15, 2019] was undertaken with the
Highlights
Evidence synthesis methods often involve a num-
ber of different non-researcher contributors
throughout the research project lifecycle. There
are varied and multiple ways of involving con-
tributors. Realist review approaches do not
always make contributor involvement explicit, in
particular patient and public involvement.
This review synthesizes the ways in which
contributors have been involved in realist
reviews, including patients and the public. Based
on our study findings, we emphasize a clear need
to identify who contributors are, when they are
involved and how, so that their impact is not lost
in future realist reviews.
For readers both inside and outside of the
realist research community, we encourage reflec-
tion, collaboration, and development of further
guidelines that help to recognize contributor
involvement in a number of different forms and
structures.
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support of an information specialist (NR). Our initial search
strategy was kept broad in order to locate as many realist
reviews as possible within healthcare. We limited the sea-
rch to English language and papers published from 2014 to
2019; conference abstracts were excluded. An example of
our search strategy can be found in Table 1.
2.2 | Study selection
Using a systematic approach, 448 papers published
between 2014 and 2019 were screened initially by RA
using title and abstract. Papers were included for full-text
screening according to the following criteria:
• Peer-reviewed articles
• Full and completed realist reviews (ie, not protocols,
not systematic reviews)
• Undertaken in any healthcare setting, in any country.
A total of 155 papers were included for full-text
screening. These papers were read in full and included if
they met the following criteria:
• Included any key words associated with contributor
involvement such as: stakeholder(s), PPI/contribution,
expert(s) panel/group, and advisory panel/group.
We used these terms to capture the breadth of ways
contributors have been described in reviews, and to
account for the possibility of involvement not formally
labeled as PPI. Papers referring to any of these terms
were included. This step yielded a total of 71 papers mak-
ing active reference to contributor involvement. All
papers selected for inclusion were then double-screened
by JR (Figure 1).
2.3 | Data analysis
Data were analyzed by RA, JR, and SP using framework
analysis.19 Framework analysis follows a six-stage process
including familiarization, coding, developing an analyti-
cal framework, application of the analytical framework,
charting the data in a framework matrix, and interpreting
the data.19,20 It is a rigorous, systematic, and transparent
process for data management and its flexible, iterative
nature means that it is well-suited to our review pro-
cess.21 Our framework analysis matrix can be found in
the supplementary material. To help guide our analysis,
and as part of an iterative process between the authors,
we asked the questions set out in Table 2 of our data.
3 | FINDINGS
Of the 71 papers included in this review, 16 came from
North America and five from Australia. The remaining
50 papers came from Europe, with the majority originat-
ing in the UK (n = 36). We present three categories from
the analysis of contributor involvement in healthcare
realist reviews: (1) nomenclature; (2) nature of involve-
ment; and (3) reporting impact.
3.1 | Nomenclature
A range of terminology was used to describe contributor
involvement (including PPI) in realist reviews. We have
categorized this involvement as part of our data synthesis
using the terms and delineations provided in the articles.
This includes experts/ expert/reference panels/groups
(typically comprising academics, content experts and at
times service user representatives) (n = 25); stakeholders
(typically comprising commissioners, policy-makers, ser-
vice providers, and key informants) (n = 32) and advisory
groups (typically comprising clinicians, academics, and
service providers) (n = 14).
3.1.1 | Patient involvement
Of the 71 papers included, four made direct acknowledg-
ment to patient involvement but did not label it as
such.22-25 Bunn et al22 included patients as part of their
TABLE 1 Example of search strategy used in Medline
#
▲ Searches
1 (realist adj5 [evaluat* or analys* or asses* or
intervention? or stud*]).ti,ab.
2 (realist adj5 [approach* or understand* or theor* or
methodolog* or framework*]).ti,ab.
3 (realistic adj [evaluat* or analys* or asses* or
intervention? or stud*]).ti,ab.
4 (realistic adj [approach* or understand* or theor* or
methodolog* or framework*]).ti,ab.
5 realist.ti.
6 1 or 2 or 3 or 4 or 5
7 limit 6 to (“review” or “systematic review” or systematic
reviews as topic)
8 (realist and [review or synthesis]).ti.
9 7 or 8
10 limit 9 to yr = “2014 -Current”
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stakeholder group, to provide experiential knowledge
which contributed to programme theory development.
Greenhalgh et al23 described patient involvement in the
form of an advisory group of four individuals who
provided advice throughout their review. McNeil et al24
involved 17 patients as stakeholders at a one-day work-
shop, and Papoutsi et al,25 like Bunn et al,22 included
patients as part of their stakeholder group.
3.1.2 | Public involvement
Of the 25 papers referring to “experts,” seven referred
specifically to service users who were positioned as mem-
bers of the public.26-32 The only difference between these
seven papers is seen in the work of Pearson et al,30 who
made use of the term “peer researchers” for service users
involved in their advisory group.
3.2 | Nature of involvement
Contributors termed “stakeholders” (eg, policy-makers
and service providers) tended to be involved during the
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consultations,33-35 informal stakeholder interviews to
help inform initial programme theories,36,37 and work-
shops held at the beginning of the research project.38,39
In the studies drawing on “expert” or “advisory panel/
groups” (eg, academics, clinicians), individuals were
involved in the development of research questions, the
sharing of relevant literature and aspects of data extrac-
tion or analysis.40,41
Conversely, papers reporting the involvement of
patients generally described the role of contributors as
providing expertise on experiential knowledge to inform
programme theory development,22 or advice throughout
the project.23 McNeil et al24 involved 17 patients as stake-
holders at a one-day workshop used to generate under-
standing and assumptions associated with patient
engagement to clarify the scope of their review. They also
held another workshop with 11 patients to discuss their
findings. Papoutsi et al25 held four meetings, each of
about two-hours in length across the entire project life
cycle.
3.3 | Reporting impact
A number of reviews provided a short commentary on
the impact of contributor involvement. This reporting of
impact included the ways in which a particular group or
meeting may have helped to shape emergent findings,
refine final programme theories or enhance the concep-
tual clarity of a review's mechanisms.42-44 Generally, this
type of reporting was brief but descriptive in detail. For
other reviews, the ability to report on impact was likely
to be contingent upon the point at which contributors
were involved in the various stages of the realist review.
For example, the input of experts may come at a later
stage in the project, that is, when findings and knowledge
generated from the review are disseminated, post-project
completion, as opposed to having an immediate effect.45
Other reviews have discussed contributor involvement
but then not commented on the impact of this in relation
to their review.46,47 One exception to the above descrip-
tions was De Weger et al,48 who integrated the reflections
of contributors throughout the results section of their
review. By and large, however, what counted as impact—
as “worthy” of being reported—appeared to be dependent
on an individual review team's judgment, increasing vari-
ation of reporting across realist reviews.
4 | DISCUSSION
This review of 71 papers explores the ways in which con-
tributors, including patients and the public, are involved
in realist reviews. The majority of included papers dem-
onstrate that a range of contributors are involved, but
involvement is not always clearly reported. Findings from
this review indicate that contributors, particularly
patients and public, are incorporated into already existing
structures or groups including stakeholder, expert, or
advisory panels. This may, at a later point (ie, reporting
stage), make it challenging for researchers to identify the
exact nature of involvement or contribution made, specif-
ically by patient and public contributors, if required or
asked to by funders, journal editors or other stakeholders.
Indeed, extant research indicates that contributor
involvement in research more broadly, particularly
patient involvement, is often not acknowledged or may
be inconsistently accounted for at best.1This is significant
given the increasing drive by bodies, such as the United
Kingdom's National Institute for Health Research, to
both encourage and account for contributor involvement.
The fact that contributor involvement may get “lost” in
reviews is problematic, particularly so when approaches
that foster openness and reciprocity are called for to sup-
port contributor involvement in research.49
Findings from this review also suggest that the point
at which contributors are involved in realist reviews
appears to differ across projects. Advice on contributor
involvement in other forms of evidence synthesis such as
traditional systematic reviews has been published by the
organization INVOLVE.12 Involvement might include:
(a) defining the scope of the review; (b) assisting with
keywords for literature searches; (c) suggesting relevant
literature; (d) appraising literature; (e) interpreting find-
ings; (f) disseminating results.12,50,51 In realist reviews,
contributors play an additional role in helping to devise
and reshape programme theories as the study progresses.
This demonstrates that, for realist reviews, contributor
involvement may in part be connected to specific project
milestones. As such, contributors may be expected to pro-
vide input at a higher level of conceptual complexity. It
may therefore not be necessary or appropriate to expect
or invite their involvement across an entire project cycle,
as advocated for in other types of evidence syntheses and
research.1,12,49
Inviting involvement at key stages of a realist review
respects both the expertise as well as the boundaries of
that expertise within any given stakeholder, expert or
advisory group. It is, however, unclear how to do this in a
way that is ethical (since literature reviews do not require
an ethics approval, there is no guidance on handling ethi-
cal dilemmas that may arise in using contributors' state-
ments), and transparent about the provenance of
interpretations without burdening the text of a review
and without introducing rankings of expertise that the
realist approach does not endorse. What is clear is that to
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support contributor involvement in realist reviews,
researchers need to create clear ways to communicate
what realist reviews are and how they might differ from
other forms of synthesis so that contributors and funders
understand what they are supporting and how.
Finally, findings from this review demonstrate that,
as with other forms of contributor involvement in evi-
dence synthesis and research more broadly, reporting of
involvement is poor.1,52-56 This limits the ability to artic-
ulate contributor impact because of an absence of detail
about which tasks they have involved in.52,53 The
decision-making process involved in reporting contribu-
tor involvement (or not) could be for a number of rea-
sons. For example, word count restrictions in research
publications may be one reason or there may be prag-
matic constraints such as time, funding, research
agendas, and researcher experience.54,55 In order to
move away from current constraints, Price et al1 indi-
cate a need for journals, funders, and research institu-
tions to work together to support the reporting of
contributor involvement through, for example, standard-
ized reporting measures. However, a blanket approach
to reporting contributor involvement may not be an
appropriate solution when different types of research
have different requirements or needs from their contrib-
utors, unless these can be shaped around a set of essen-
tial and desirable principles that act as guidelines as
opposed to rules.56
For realist reviews, in particular, there is a lack of
guidance or standards available on both undertaking
and reporting contributor involvement. The realist
research community could reflect on this and develop
ways to consider contributor involvement, in particular
of patients and the public. Working towards more con-
crete guidance on both the nature and reporting of
involvement in realist reviews is one way of moving
forwards. This may include drawing on existing frame-
works employed in other modes of evidence synthesis
that help to articulate tasks and roles for contributor
involvement.52,53
As a result of the findings presented above, and in
collaboration with two patient representatives, we gen-
erated a series of prompts for both researchers and
contributors involved in a realist review. These pro-
mpts are available online57 and recognize the need for
and purpose of contributor involvement to differ
between projects. These prompts, which are supported
by our review's findings, could form a foundation and
stimulus for future research to develop recommenda-
tions on the role of contributors, such as patients and
the public, in realist reviews, and provide guidance to
support researchers in their future collaboration with
contributors.
4.1 | Strengths and limitations
Whilst all the full-text articles included in this study were
double-screened, the initial screening of title and abstract
was single screened by one reviewer. We did not conduct
any quality appraisal of the included reviews. Had we
found sufficient variability in the quality of reporting of
contributor involvement across reviews, it would have
been informative to consider if this correlated with other
parameters of higher review quality. However, since the
reporting of involvement varied across all reviews, it was
of no direct value to the goals of the study to carry out
individual quality appraisals.
We did not explicitly include additional contributors
such as patients or the public in our review as the
research required the skills of trained individuals with
knowledge of data screening, extraction, and analysis,
skills, which were largely present in our research team.
However, during this review, we did feel a need to reflect
on the role of patients and their perspective in terms of
contributing to evidence syntheses and, as indicated,
developed with two patient representatives a series of
reflective prompts to support contributor involvement in
realist reviews.
5 | CONCLUSION
This review has synthesized the terminology, nature,
and reported impact of contributor involvement across
healthcare realist reviews published in the last five
years. Whilst the majority of included articles demon-
strate that a range of contributors are involved in realist
reviews, this synthesis has highlighted the variation
across reviews and under-reporting of contributor
involvement. In particular, PPI is not always made dis-
tinct from other types of involvement. The limited guid-
ance available to realist reviewers regarding contributor
involvement hinders this aspect of research transpar-
ency and knowledge generation, which is a crucial part
of contributor involvement, particularly for realist
reviews and programme theory development. As a
result, there is now a clear opportunity to shape the
role of contributor involvement, including PPI, in realist
reviews by developing guidance to support researchers
in their future collaborations.
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